Price Alert

Sanofi (SNY)

NASDAQ: SNY · Real-Time Price · USD

49.77

0.73 (1.49%)

At close: Aug 15, 2025, 3:59 PM

49.75

-0.05%

After-hours: Aug 15, 2025, 07:35 PM EDT

Sanofi Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	15.36B	7.99B	7.44B	n/a	6.79B	-8.71B	8.71B	-7.99B	7.99B	-12.74B	12.74B	-6.9B	6.9B	-10.11B	10.1B	-9.72B	9.72B	-13.91B
Short-Term Investments	n/a	n/a	486M	n/a	n/a	17.42B	n/a	15.99B	n/a	25.47B	n/a	13.8B	n/a	20.22B	n/a	19.44B	n/a	27.83B
Long-Term Investments	7B	n/a	3.26B	n/a	3.23B	n/a	3.26B	n/a	3B	n/a	3.22B	n/a	3.29B	n/a	2.91B	n/a	2.66B	n/a
Other Long-Term Assets	1.22B	12.71B	1.37B	-6.79B	551M	-8.71B	588M	-7.99B	1.04B	-12.74B	882M	-6.9B	1.2B	-10.11B	731M	-9.72B	501M	-13.91B
Receivables	8.21B	447M	10.63B	n/a	8.8B	n/a	11.04B	n/a	8.64B	n/a	10.75B	n/a	8.41B	n/a	9.79B	n/a	7.42B	n/a
Inventory	9.62B	21.85B	9.43B	n/a	10.61B	n/a	9.67B	n/a	9.97B	n/a	8.96B	n/a	9.37B	n/a	8.71B	n/a	9.26B	n/a
Other Current Assets	3.83B	13.73B	13.71B	n/a	3.87B	n/a	471M	n/a	3.37B	n/a	870M	n/a	3.69B	n/a	1.35B	n/a	3.09B	n/a
Total Current Assets	37.02B	44.02B	42.59B	6.79B	30.08B	8.71B	30.66B	7.99B	29.98B	12.74B	34.03B	6.9B	28.36B	10.11B	30.56B	9.72B	29.5B	13.91B
Property-Plant & Equipment	11.01B	11.35B	11.6B	n/a	11.88B	n/a	11.81B	n/a	11.53B	n/a	11.68B	n/a	11.64B	n/a	11.98B	n/a	10.98B	n/a
Goodwill & Intangibles	60.71B	63.81B	66.01B	n/a	76.73B	n/a	73.72B	n/a	73.83B	n/a	71.53B	n/a	72.53B	n/a	69.46B	n/a	64.44B	n/a
Total Long-Term Assets	87.94B	87.87B	90.21B	-6.79B	99.68B	-8.71B	95.81B	-7.99B	95.38B	-12.74B	92.7B	-6.9B	93.47B	-10.11B	89.68B	-9.72B	82.82B	-13.91B
Total Assets	124.96B	131.89B	132.8B	n/a	129.75B	n/a	126.46B	n/a	125.35B	n/a	126.72B	n/a	121.83B	n/a	120.24B	n/a	112.32B	n/a
Account Payables	7.08B	21.62B	7.55B	n/a	7.43B	n/a	7.33B	n/a	7.37B	n/a	6.81B	n/a	6.56B	n/a	6.18B	n/a	5.37B	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	264M	n/a	n/a	n/a	319M	n/a	n/a	n/a
Short-Term Debt	7.31B	7.37B	4.22B	n/a	9.52B	n/a	2.32B	n/a	4.95B	n/a	4.45B	n/a	3.29B	n/a	3.45B	n/a	2.47B	n/a
Other Current Liabilities	13.7B	2.19B	15.12B	n/a	12.95B	n/a	11.84B	n/a	12.07B	n/a	11.86B	n/a	11.77B	n/a	10.61B	n/a	10.69B	n/a
Total Current Liabilities	29.06B	32.22B	29.16B	n/a	30.03B	n/a	24.19B	n/a	24.76B	n/a	23.96B	n/a	22.06B	n/a	21.3B	n/a	19.13B	n/a
Long-Term Debt	13.2B	11.77B	11.79B	n/a	12.5B	n/a	14.35B	n/a	14.24B	n/a	14.86B	n/a	15.94B	n/a	17.12B	n/a	17.93B	n/a
Other Long-Term Liabilities	9.18B	9.78B	10.18B	-73B	10.7B	n/a	9.96B	n/a	9.62B	n/a	9B	n/a	8.97B	n/a	9.34B	n/a	8.98B	n/a
Total Long-Term Liabilities	25.62B	25.25B	25.78B	-73B	26.73B	n/a	27.92B	n/a	27.65B	n/a	27.61B	n/a	28.46B	n/a	29.92B	n/a	29.83B	n/a
Total Liabilities	54.68B	57.47B	54.94B	-73B	56.76B	n/a	52.11B	n/a	52.41B	n/a	51.57B	n/a	50.52B	n/a	51.21B	n/a	48.96B	n/a
Total Debt	22.29B	21.05B	17.91B	n/a	23.75B	n/a	18.42B	n/a	21.03B	n/a	21.21B	n/a	21.24B	n/a	22.41B	n/a	21.65B	n/a
Common Stock	2.46B	n/a	2.53B	n/a	2.53B	n/a	2.53B	n/a	2.52B	n/a	2.52B	n/a	2.53B	n/a	2.53B	n/a	2.52B	n/a
Retained Earnings	n/a	n/a	n/a	n/a	65.09B	n/a	67.5B	n/a	65.69B	n/a	66.73B	n/a	61.88B	n/a	63.01B	n/a	59.05B	n/a
Comprehensive Income	63.09B	n/a	70.56B	72.69B	6.12B	74.04B	4.88B	72.63B	5.23B	74.78B	6.11B	70.95B	7.15B	68.68B	3.55B	63.24B	2B	63B
Shareholders Equity	70.01B	74.07B	77.51B	73B	72.69B	74.35B	74.04B	72.95B	72.63B	75.15B	74.78B	71.3B	70.95B	69.03B	68.68B	63.36B	63.24B	63.15B
Total Investments	7B	n/a	3.75B	n/a	3.23B	17.42B	3.26B	15.99B	3B	25.47B	3.22B	13.8B	3.29B	20.22B	2.91B	19.44B	2.66B	27.83B